Navigation Links
Radiation After Surgery Lowers Chances of Breast Cancer's Return
Date:12/8/2010

TUESDAY, Dec. 7 (HealthDay News) -- Women with localized breast cancer are less likely to develop invasive cancer if they receive radiation after surgery, a new study finds.

The researchers also found that treatment with the drug tamoxifen greatly reduced the risk of the recurrence of localized cancer.

The three-nation study included patients with ductal carcinoma in situ (DCIS), the most common type of noninvasive breast cancer, who were followed for a median of 12.7 years.

The researchers found that radiation after surgery reduced the risk of invasive cancer in the same breast by nearly 70 percent and decreased recurrent DCIS in the same breast by more than 60 percent. Radiation therapy had no effect on the other breast.

"This study is very important in confirming the benefits of radiotherapy in the treatment of ductal carcinoma in situ and, most importantly, decreasing the incidence of invasive carcinoma developing in the same breast," said Dr. Lauren Cassell, chief of breast surgery at Lenox Hill Hospital in New York City. "If we could only identify which particular patients were most at risk, we could target our radiotherapy to those patients who truly benefit from it and avoid over-treating others."

The study also found that treatment with tamoxifen lowered the risk of cancer recurrence in the same breast by about 30 percent, and it decreased the risk of new cancer in the other breast by more than 65 percent.

The findings appear online Dec. 7 in The Lancet Oncology.

The findings confirm "the long-term beneficial effect of radiotherapy and reports a benefit for tamoxifen in reducing local and contralateral new breast events for women with DCIS treated by complete excision," study author Jack Cuzick, of Cancer Research U.K. and Queen Mary's School of Medicine and Dentistry in London, and colleagues wrote in a news release from the journal.

"This trial emphasizes the importance of radiotherapy in high-grade [more quickly growing and more likely to spread] DCIS and also suggests a role for tamoxifen, primarily for new contralateral disease," they concluded.

More information

The American Cancer Society has more about breast cancer.

-- Robert Preidt

SOURCES: The Lancet Oncology, news release, Dec. 7, 2010; Lauren Cassell, M.D., chief, breast surgery, Lenox Hill Hospital, New York City


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Seeks Reduction in Radiation From Medical Scans
2. For Some Breast Cancer Patients, Shorter Radiation Works Well
3. Short-term radiation therapy successful on breast cancer
4. ASCROs Response to NY Times Articles on Radiation Therapy Incidents
5. Imaging manufacturers: Plan to reduce unnecessary radiation exposure and medical errors
6. Roseville Radiation Oncology Center (ROC) Redefines Efficiency With Elekta VMAT Radiotherapy Treatments
7. New cardiac CT technology drastically reduces patient radiation exposure
8. New Heart CT Scans Deliver Far Less Radiation: Study
9. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
10. Delaying post-surgical radiation increases risk of breast cancer recurrence in older women
11. Radiation Most Effective Soon After Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Radiation After Surgery Lowers Chances of Breast Cancer's Return 
(Date:2/23/2017)... ... 2017 , ... The 89th Academy Awards will be celebrated this weekend, which ... Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to ... the Center for American Progress (CAP), for its report, Lessons From State Performance on ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb 24, 2017 Research and ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... drug pricing data and benchmarks in the global Urinary Incontinence market. ... What are the key drugs marketed for Urinary Incontinence and ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
Breaking Medicine Technology: